Wow. Scary! Maybe, we should consider using digital therapies. ✅safe✅reduces alcohol consumption✅hospitalisation @alcochange@CyberLiver@drgautammehta@rkumar awaiting the final results of NIHR funded trial in 320 patients in the UK. Could be a game changer @NIHRresearch
A summary of the indications, dosing, targets, and follow-up for beta-blockers in cirrhosis, based on the Rodrigues SG, et al. article in JHEP Reports.
https://t.co/RkKYHkJrOT
@cirhhocare Prospective multicentre RCTin #realworld to assess the clinical effectiveness of the novel CirrhoCare digital therapeutic management system #cirrhosis#livertwitter
❤️ Heartfelt thanks to the incredible staff across all 26 NHS hospitals who made the @alcochange trial recruitment possible! Your dedication to helping patients with alcohol-related liver disease is inspiring. A right step in changing lives of many! #LiverTwitter#digitalmedicine